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Abstract
Background: The microbiota of the bovine upper respiratory tract has been recently characterized, but no data for
the lower respiratory tract are available. A major health problem in bovine medicine is infectious bronchopneumonia,
the most common respiratory syndrome affecting cattle. With this study, we used 16S rRNA gene sequencing
to characterize and compare the microbial community composition of the upper and lower respiratory tracts
in calves.
Results: The microbiota of the upper (nasal swab [NS]) and the lower (trans-tracheal aspiration [TTA]) respiratory tracts of
19 post-weaned Piedmontese calves with (8/19) and without (11/19) clinical signs of respiratory disease, coming from six
different farms, was characterized by 16S rRNA gene metabarcoding. A total of 29 phyla (29 in NS, 21 in TTA)
and 305 genera (289 in NS, 182 in TTA) were identified. Mycoplasma (60.8%) was the most abundant genus identified
in both the NS (27.3%) and TTA (76.7%) samples, followed by Moraxella (16.6%) in the NS and Pasteurella (7.3%) in the
TTA samples. Pasteurella multocida (7.3% of total operational taxonomic units [OTUs]) was the most abundant species
in the TTA and Psychrobacter sanguinis (1.1% of total OTUs) in the NS samples. Statistically significant differences between
the NS and the TTA samples were found for both alpha (Shannon index, observed species, Chao1 index, and Simpson
index; P = 0.001) and beta (Adonis; P = 0.001) diversity. Comparison of the NS and TTA samples by farm origin and clinical
signs revealed no statistical difference (P > 0.05), except for farm origin for the NS samples when compared by the
unweighted UniFrac metric (P = 0.05).
Conclusions: Using 16S rRNA gene sequencing, we characterized the microbiota of the upper and lower respiratory
tracts of calves, both healthy individuals and those with clinical signs of respiratory disease. Our results suggest that
environmental factors may influence the composition of the upper airway microbiota in cattle. While the two microbial
communities (upper and lower airways) differed in microbial composition, they shared several OTUs, suggesting that
the lung microbiota may be a self-sustaining, more homogeneous ecosystem, influenced by the upper respiratory tract
microbiota.
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Background
In the last decade, the use of high-throughput sequencing
methods (next-generation sequencing, NGS) coupled to
DNA barcoding has advanced the study of bacterial com-
munities as a whole [1]. DNA metabarcoding allows the
generation of multiple reads of the hypervariable regions of
the 16S rRNA gene in a single run, thus yielding a wealth
of phylogenetic information in a single experiment [1]. The
16S rRNA gene metabarcoding approach applied to lower
respiratory tract samples from humans led to the discovery
that the lung is not sterile even in healthy conditions [2].
The finding of lung microbiota in a healthy subject was ini-
tially explained as a temporal contamination from the
upper respiratory tract either during sampling or by micro-
aspiration [3]. However, recent studies have shown that the
microbiota of the lung could be considered an ecosystem
and that its composition depends on the immigration,
elimination, and reproduction rates of the microbial com-
munities present there [4–6]. Though the components of
this ecosystem derive from the upper respiratory tract, they
could be able to proliferate in the lungs and form a self-
sustaining lung microbiota [4–6]. DNA metabarcoding
analysis of pathological respiratory samples led to the hy-
pothesis that alteration of the lung microbiota could as-
sume a key role in the pathogenesis of human lung
diseases, including bacterial pneumonia [6, 7].
Study of the bovine respiratory tract holds huge im-
portance because one of the main health issues in the
cattle industry is infectious bronchopneumonia, defined
as bovine respiratory disease (BRD) [8, 9]. In Europe,
BRD is associated with high morbidity and mortality,
which leads to a widespread use of antimicrobials and,
therefore, increases the alarm about antibiotic resistance
[10–19]. BRD is a multifactorial disease resulting from
interactions between management, physiologic, and en-
vironmental factors and etiological agents [20, 21]. The
bacterial pathogens most often identified by culture-
based methods in the course of BRD are Mannheimia
haemolytica, Pasteurella multocida, Histophilus somni,
and Mycoplasma bovis [22]. Considered ubiquitous in-
habitants of the bovine upper respiratory tract, these
bacterial species can proliferate in the lungs when in-
haled during stressful events or viral infections [22].
However, they have also been isolated from the lower re-
spiratory tract of calves not presenting clinical signs,
raising questions about their role in the development of
BRD [23, 24]. A better understanding of the etiology of
BRD is critical to improve animal health.
In cattle, 16S rRNA gene metabarcoding to characterize
the microbiota of the upper respiratory tract has been ap-
plied on nasal swab samples from dairy and beef calves
[25–31]. Timsit et al. [26] and Holman et al. [28], for ex-
ample, reported that the upper respiratory tract micro-
biota of beef cattle is not stable in the first 40 days on
feedlot, possibly explaining their higher susceptibility for
developing BRD in this period. Moreover, Lima et al. [31]
found that the upper respiratory tract microbiota of dairy
calves significantly differed depending on the animal’s
clinical respiratory status. The application of this new
technique to respiratory tract samples has attracted in-
creasing interest; however, to our knowledge, data about
the bovine lower respiratory tract microbiota are still lack-
ing. The goal of this study was to characterize the
microbiota of the upper and lower respiratory tracts by
applying 16S rRNA gene metabarcoding on nasal swab
(NS) and trans-tracheal aspiration (TTA) samples from
post-weaned Piedmontese calves with and without clinical
signs of BRD.
Methods
Sample population and sample collection
The study was performed in Piedmont, northwest Italy.
The six farms included in the study were located in the
provinces of Torino (TO), Cuneo (CN), and Vercelli
(VC). The median distance as the crow flies between the
farms was 50 km (min-max, 11–97 km) (map given in
Additional file 1). The six farms were located in a re-
stricted area with similar geographical and climatic char-
acteristics. The farms were all cow-calf operations with
the same animal management. Briefly, the calves were
held with the mother until the end of the weaning
period (5 months), then moved to multiple straw-
bedded boxes (5–10 animals) with free access to water
and feed (roughage and concentrate).
The animals included were post-weaned Piedmontese
calves receiving veterinary care by the Veterinary Teaching
Hospital of the University of Turin. Medical history and
physical examination data were collected via a standardized
collection form for each calf. A complete physical examin-
ation was performed for all animals focusing on typical
clinical signs of BRD: cough, nasal discharge, and abnormal
sounds at thoracic auscultation (wheezes, crackles) (Master
Classic II™, 3M Littmann® stethoscope, 3M, St. Paul, MN,
USA). Calves that had been treated in the week prior to
examination or presented clinical signs suggestive of dis-
eases different from BRD were excluded from the study.
Nasal swab (NS) samples were collected using sterile
swabs (17 cm, DrySwab, Copan S.p.A, Italy) from both
nostrils of each calf after cleaning the nostrils with 90%
ethyl alcohol. Trans-tracheal aspiration (TTA) was per-
formed as previously described [23]. Briefly, the animals
were mildly sedated with intravenous injection of
0.05 mg/kg Xylasine (Rompun®, Bayer Healthcare,
Germany), and an area of 3 × 3 cm about 7–10 cm cau-
dal to the larynx was shaved and surgically prepared
with 90% ethyl alcohol and iodophors. The area was
desensitized with 4% procaine hydrochloride (Aticain®,
A.T.I., Italy), and a longitudinal 1-cm incision was then
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placed in the midline directly above the trachea. A 12-G
needle was used to perforate the trachea between two
cartilage rings. A male dog urinary catheter (2 mm ×
50 cm; Buster, sterile dog catheter, Kruuse, Germany)
was introduced into the needle and pushed down into
the airway for about 45 cm. Finally, a volume of 50 ml
sterile 0.9% saline solution was injected through the
catheter and immediately aspirated. To prevent sample
contamination, a new sterile kit and a new pair of sterile
gloves were used for each calf. All samples were stored
at − 80 °C until analysis.
DNA extraction and library preparation
DNA extraction
DNA was isolated using DNAzol® reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s in-
structions. Briefly, the NS were dipped in 500 μl of
DNAzol® reagent immediately after collection, while the
TTA fluids were pelleted and added with 1 ml of DNA-
zol® reagent, after thawing at 4 °C. The samples were
then repeatedly homogenized and incubated at 4 °C for
18 h. After DNA precipitation by means of ethanol, the
pellets were rinsed twice. Finally, DNA was eluted in
30 μl of RNase and DNase free water. The DNA concen-
tration of each sample was determined using a Qubit
fluorimeter (Qubit®, Invitrogen) and normalized to 5 ng/
μl. Samples with a lower DNA concentration were not
processed further.
Library preparation
The normalized DNA was processed according to the
16S Metagenomic Sequencing Library Preparation
protocol as recommended by Illumina (Illumina, San
Diego, CA, USA). Briefly, 12.5 ng of genomic DNA
underwent an initial PCR step with the 16S amplicon
PCR forward and reverse primers targeting the V3 and
V4 regions of the 16S rRNA gene [32], followed by PCR
cleanup with Agencourt Ampure XP (Beckman Coulter,
Brea, CA, USA) magnetic beads, and index PCR for a
second cleanup with magnetic beads. Normalization was
based on the average size of the library as assessed with an
Agilent High Sensitivity DNA Kit on a 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA) and quanti-
fication with a NEBNext® Library Quant Kit for Illumina®
(New England Biolabs, Ipswich, MA, USA) normalization.
The normalized libraries were eventually pooled and
loaded for sequencing on an Illumina MiSeq platform
with paired-end 2 × 300 bp protocol using a MiSeq®
Reagent Kit ver. 3 (600 cycles) (Illumina).
Neither blank controls nor mock communities were
included in the present study; however, in order to limit
the influence of contamination by extraction and ampli-
fication on the analysis, all samples were processed using
the same DNA extraction reagents, and the amplifica-
tions were conducted with the same reagent lots.
Bioinformatic and statistical analysis
Reads were processed for quality filtering (using Q30 as
threshold), adapter and primer removal BBDuk2 ver.
36.14; mate pairing was performed with BBMerge ver.
9.00 (https://sourceforge.net/projects/bbmap/). The fasta
files were then processed using a Quantitative Insights
Into Microbial Ecology (QIIME) 1.9.1 pipeline [33]. In
detail, paired reads were merged in a single fasta file
with multiple_split_libraries_fastq.py script, which pro-
vides further quality filtering. Operational taxonomic
unit (OTU) picking was performed with the pick_open_-
reference_otus.py using the UCLUST method and with
97% identity to the Greengenes (version gg_13_8) refer-
ence database, followed by de novo clustering [34]. Rep-
resentative sequences were checked for de novo chimera
detection using ChimeraSlayer integrated in QIIME, and
the chimeras were then filtered out from the OTU table
[35]. The alpha and beta diversities were computed with
the core_diversity_analyses.py script, rarefying the sam-
ples at 2500 reads. Samples with less than 2500 reads
were excluded from the statistical analysis because these
were not representative. Phyla, genera, and species
abundance was reported as overall relative abundance,
average relative abundance, and standard error of the
mean (SEM).
Statistical support to the alpha diversity comparison be-
tween groups was assessed by nonparametric test with
Monte Carlo permutations implemented in the compare_-
alpha_diversity.py script, while for the variance within and
between groups, QIIME wrapper compare_categories.py was
applied with permutational multivariate analysis of variance
(PERMANOVA, Adonis method from R package Vegan im-
plemented in QIIME). Statistically significant differences in
OTU frequencies based on non-normalized raw counts be-
tween the NS and TTA samples from clinically healthy ani-
mals and those presenting at least one clinical sign
suggestive of BRD were assessed using the differential_-
abundance.py script that implements the R package DESeq2
[36], and P values were adjusted (Padj) for multiple-testing
with the false discovery rate (FDR) procedure of Benjamini
and Hochberg [37]. OTUs were considered differentially
abundant if at Padj ≤ 0.05 and if the estimated fold change
was > 1.5 or < 1/1.5.
In order to evaluate the type I and type II errors and
strengthen the results, we performed a power analysis
on the data grouped by sample type, and by sample type
and clinical signs according to the method presented by
La Rosa and colleagues, implemented in the R package
HMP, using the MC.Xmcupo.statistics function and 1000
Monte Carlo experiments [38].
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Results
Study population
The number of calves selected from each farm ranged
from 1 to 7, for a total of 22 calves (17 males and 5
females), aged from 5 to 14 months. Thirteen out of 22
animals (59%) were clinically healthy, and the remaining
nine showed at least one clinical sign attributable to
BRD (Table 1). Nasal swab samples were collected from
17 out of 22 animals, and TTA samples were collected
from all animals. DNA was successfully extracted at a
concentration above 5 ng/μl from 32 samples (13 NS
and 19 TTA fluid samples). In one of the nine animals
presenting clinical signs, the DNA concentration was
below 5 ng/μl in both the NS and TTA samples; this
animal was excluded from the study. At least one
sample (NS or TTA) from 21 out of 22 calves was avail-
able for analysis. Further details regarding the study
population are reported in Table 1.
Genetic analysis
After primer and quality trimming and pair merging, the
total read count was 3,482,819, with an average read
Table 1 Data about calves (origin, signalment, history, clinical examination) and number of reads of each sample
ID Farm Age
(months)
Sex Weight
(kg)
Previous
episodes of
BRD
Spontaneous
cough
Nasal
discharge
Abnormal lung sounds Read number
NS sample
Read number
TTA sample
1a TO1 14 M 400 3 months
before sampling
Repeated Cloudy and
bilateral
Wheezes and crackles on the left
side of the thorax
NP 53,494
2b CN1 6 M 180 No Absent Absent Absent NP 7902
3a CN1 6 M 180 1 month before
sampling
Occasional Absent Wheezes and crackles on both
sides of the thorax
NP 47,115
4b CN1 6 M 180 No Absent Absent Absent NP 18,855
5b CN1 6 M 180 No Absent Absent Absent NP 81,564
6a CN2 6 M 180 No Absent Cloudy and
unilateral
Absent 36,160 129,750
7b CN2 6 M 180 No Absent Absent Absent 28,543 118,454
8b CN2 6 M 180 No Absent Absent Absent 31,232 61,778
9a CN2 6 M 180 No Absent Cloudy and
bilateral
Wheezes and crackles on both
sides of the thorax
DNA < 5 ng/
μl
DNA < 5 ng/μl
10a VC1 5 F 150 No Repeated Absent Wheezes and crackles on both
sides of the thorax
40,694 142,459
11a VC1 5 F 150 2 months
before sampling
Absent Absent Wheezes and crackles on both
sides of the thorax
12,952 DNA < 5 ng/μl
12b VC1 5 F 150 No Absent Absent Absent 5988 DNA < 5 ng/μl
13a VC1 5 M 150 No Absent Absent Wheezes and crackles on both
sides of the thorax
24,070 26,910
14b TO2 6 M 200 No Absent Absent Absent DNA < 5 ng/
μl
68,954
15b TO2 6 F 200 No Absent Absent Absent 20,464 40,790
16a TO2 6 F 200 No Absent Absent Wheezes and crackles on the right
side of the thorax
167,198 107,679
17a TO2 6 F 200 No Absent Cloudy and
bilateral
Absent DNA < 5 ng/
μl
143,886
18b TO2 6 M 200 No Absent Absent Absent 3932 55,630
19b TO2 6 M 200 No Absent Absent Absent DNA < 5 ng/
μl
1,825c
20b TO2 6 M 200 No Absent Absent Absent 154,004 4585
21b TO3 5 M 170 No Absent Absent Absent 1,536c 6833
22b TO3 5 M 170 No Absent Absent Absent 159c 189c
ID = animal’s identification number. Farm origin = farms are indicated with the provincial code (TO Torino, CN Cuneo, VC Vercelli) and progressively numerated.
Sex: M = male, F = female. Read number = number of reads for each sample. TTA = trans-tracheal aspiration sample. NS = nasal swab sample. NP = not performed.
DNA < 5 ng/μ = samples with DNA concentration lower than 5 ng/μl and not sequenced
aCalves with clinical signs of BRD
bHealthy calves
cSamples with less than 2500 reads excluded from the final analysis
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length of 407 ± 80 bp. After application of the
multiple_split_libraries_fastq.py script to merge all the
sequences in a single file, with further quality checks,
the read number was 2,813,497. The total reads classified
in the OTU table was 1,645,584, divided in 526,932 from
the NS samples (median 24,072, min-max 159–167,198)
and 1,118,652 from the TTA fluid samples (median
53,494, min-max 189–143,886). The number of assigned
reads was below 2500 in 4 (2 NS and 2 TTA) out of 32
samples, and they were excluded from the analysis. There-
fore, the final analysis was performed on 28 samples (11
NS and 17 TTA) from 19 calves (8 with clinical signs, 11
clinically healthy). Of these 28 samples, 18 (64.3%) were
matched samples from the same animal (9 NS and 9
TTA) (Table 1). Finally, the reads obtained from these 28
samples were classified in 4368 OTUs (median 226.5,
min-max 44–2502). The median (min-max) of the OTUs
was 957 (495–2502) in the NS samples and 139 (44–719)
in the TTA samples. A total of 810 unique sequences were
classified as chimeric sequences and therefore removed
from the OTU table before analysis.
Phylum composition
Overall, 29 phyla were identified. The microbial commu-
nity of the samples was structured as follows: Teneri-
cutes (61.8%, 59% ± 5.6%), Proteobacteria (19%, 15.6% ±
3.2%), Firmicutes (6.5%, 8.1% ± 2.2%), Bacteroidetes
(5.6%, 7.2% ± 1.8%), Actinobacteria (3.8%, 7.1% ± 2%),
Fusobacteria (2.8%, 1.6% ± 1.1%), others (0.3%, 0.4% ±
0.1%), and unassigned (0.2%, 1.1% ± 0.9%). Of the 29
phyla identified in the NS samples, the most abundant
were Proteobacteria (36.1%, 21.9% ± 5.3%), Tenericutes
(27.7%, 35.4% ± 6.9%), Firmicutes (18.4%, 19.3% ± 3.3%),
Bacteroidetes (10.1%, 10.8% ± 2.5%), and Actinobacteria
(6.3%, 8.9% ± 1.6%). Only 21 out of 29 phyla were identi-
fied in the TTA fluid samples, and the most abundant
were Tenericutes (77.9%, 74.3% ± 5.6%), Proteobacteria
(11.0%, 11.4% ± 3.7%), Fusobacteria (4.2%, 2.5% ± 1.7%),
Bacteroidetes (3.5%, 4.8% ± 2.4%), and Actinobacteria
(2.6%, 5.9% ± 3.2%). Figure 1 presents the phylum
abundance and composition in the upper and lower
respiratory tracts.
Genera and species composition
A total of 305 genera were identified: 289 in the NS sam-
ples and 182 in the TTA samples. Overall, the most abun-
dant genera were Mycoplasma (60.7%, 58.1% ± 8.9%),
Moraxella (5.5%, 2.6% ± 3%), and Pasteurella (5.2%, 4.9%
± 3.7%). Four other genera with a relative abundance
higher than 1% were identified: Sphingomonas (1.2%, 1.1%
± 0.6%), Mannheimia (1.2%, 0.9% ± 0.9%), Aggregatibacter
(1.2%, 0.5% ± 0.6%), and Bacteroides (1.1%, 1.2% ± 1.7%).
Mycoplasma was the most abundant genus in both the NS
and the TTA fluid samples, with a relative abundance of
Fig. 1 Average relative abundance of phyla in the nasal swab (NS) and trans-tracheal aspiration (TTA) samples. Only phyla with a relative
abundance higher than 1% in at least one sample type were represented. Blue columns represent NS (n = 11) samples, while red columns
represent TTA (n = 17). The bars represent the standard error of the mean
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27.2% (35.1% ± 6.9%) and 76.5% (72.9% ± 5.5%), respect-
ively, followed by Moraxella (16.6%, 5.9% ± 4.8%) in the
NS samples and by Pasteurella (7.3%, 7.6% ± 3.7%) in the
TTA samples. A few other genera with an abundance >
1% were also found in the NS samples [Aggregatibacter
3.6% (1.2% ± 1%), Sphingomonas 3.4% (2.5% ± 0.8%),
Corynebacterium 1.3% (1.6% ± 0.2%), Psychrobacter 1.2%
(1.6% ± 0.6%), Coprococcus 1% (1% ± 0.2%)] and the TTA
samples [Mannheimia 1.6% (0.7% ± 0.6%), Bacteroides
1.5% (1.8% ± 1.8%), Ureaplasma 1.3% (1.2% ± 0.6%)]
(Fig. 2).
Besides Mycoplasma, present in all samples, Delftia,
Sphingomonas, and Agrobacterium composed the core
biota of 90% of the samples. Twelve OTUs were
present in all NS samples, including seven orders
(Aeromonadales, Actinomycetales, Clostridiales,
Flavobacteriales, Mycoplasmatales, Saprospirales, and
Sphingomonadales) and four genera (Succinivibrio,
Mycoplasma, Sphingomonas, and Corynebacterium).
Overall, 123 out of 305 genera were found only in
the NS samples and 16 genera only in the TTA sam-
ples (Additional file 2: Table S1).
Considering only the OTUs assigned at the species
level, Pasteurella multocida (7.3% of total OTUs, 7.6% ±
3.7%) was the most abundant in the TTA fluid samples
and Psychrobacter sanguinis (1.1% of total OTUs, 1.5%
± 0.6%) in the NS samples. The complete list of all
species identified, when possible, is reported in
Additional file 2: Table S2.
Comparison of bacterial composition between TTA fluid
and NS samples
Alpha diversity values are reported in Table 2. Good’s
coverage estimate with a rarefaction at 2500 was 91.6%
± 2.9% for the NS and 99% ± 0.9% for the TTA fluid
samples. The alpha diversity indices and rarefaction
curves of each sample are reported in Additional file 3.
There was a statistically significant difference in Shan-
non’s diversity index between the TTA fluids and the NS
samples, considering the confidence interval. The micro-
bial composition of the upper and lower respiratory
tracts was compared by Bray-Curtis dissimilarity,
weighted UniFrac, and unweighted UniFrac phylogenetic
distances. The difference between the two bacterial com-
munities was statistically significant as assessed by
Adonis (P = 0.001), based on the three different distance
matrices. Principal coordinates analysis (PCoA) plots of
the methods are shown in Fig. 3. The type I error with a
significance at 0.05 was < 0.001, as was the type II error,
providing a power > 90%.
There were 741 OTUs with a statistically significant
difference in abundance (as assessed by DESeq2 analysis)
(details given in Additional file 4), with 19 more
abundant in the TTA microbiota and 722 in the NS one.
Fig. 2 Average relative abundance of genera in the nasal swab (NS) and trans-tracheal aspiration (TTA) samples. Only bacterial genera with a
relative abundance higher than 1% in at least one sample type were represented. Blue columns represent NS (n = 11) samples, while red columns
represent TTA (n = 17). The bars represent the standard error of the mean
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Correlation of microbiota composition of NS and TTA
fluid samples in relation to clinical status and farm of origin
Comparison of the microbiota composition of the TTA
samples by farm of origin showed no statistically significant
difference for this factor (Adonis on either Bray-Curtis
dissimilarity, weighted UniFrac, or unweighted UniFrac
distance; P > 0.05). It was not possible to estimate the type
I and II errors because one group had size = 1. Similarly,
no statistical difference in the microbiota composition of
the NS samples was found when two statistical methods
(Adonis on Bray-Curtis dissimilarity and weighted UniFrac
distances; P > 0.05) were applied, except when compared
based on unweighted UniFrac distance (P = 0.05). The type
I error with a significance at 0.05 was < 0.001, as well as
the type II error, providing a power > 90%. Finally, no cor-
relation was found between the presence or absence of
clinical signs and microbial composition of the NS and the
TTA samples (Adonis on Bray-Curtis dissimilarity,
weighted UniFrac, or unweighted UniFrac distance; P >
0.05, power > 90%).
Discussion
To the best of our knowledge, this is the first study
using the 16S rRNA gene metabarcoding approach to
characterize and compare the microbiota of the upper
and lower respiratory tracts in calves with and without
clinical signs of BRD. Recent studies have demonstrated
the presence of several bacterial communities in the bo-
vine nasopharynx, documenting that potential patho-
genic bacteria are common inhabitants of the upper
respiratory tract in cattle [25–31]. Our results are in
agreement with the literature as regards the high num-
ber of phyla identified and the fact that five phyla seem
to be dominant in the bovine upper respiratory tract
microbiota: Proteobacteria, Tenericutes, Firmicutes,
Actinobacteria, and Bacteroidetes [25, 26, 28–31].
Moreover, we found that the microbiota of the upper
respiratory tract differs depending on the animals’ farm
of origin. However, the number of calves was not equally
distributed among the farms, and this difference was sta-
tistically significant based only on the unweighted Uni-
Frac distance, which accounts for the presence/absence
of observed OTUs. While it is difficult to draw general
conclusions from the present data and further studies
Table 2 Alpha diversity indexes calculated for the nasal swab
(NS) and trans-tracheal aspiration (TTA) samples
TTA NS P value
Chao1 index 95.62 ± 78.48 720.74 ± 225.22 0.001
Observed species 40.57 ± 35.21 395.30 ± 152.62 0.001
Shannon index 1.46 ± 0.83 5.14 ± 1.74 0.001
Simpson index 0.45 ± 0.24 0.82 ± 0.13 0.001
Chao1 index, observed species, Shannon’s diversity index, and Simpson index
values are reported as mean ± standard error
Fig. 3 Principal coordinates analysis (PCoA) 3D images. PCoA was performed using Bray-Curtis dissimilarity (a), unweighted UniFrac (b), and
weighted UniFrac (c) distance matrices. Each sample is represented by a point with nasal swabs (NS = 11) in blue and trans-tracheal aspiration
(TTA = 17) in red. The clustering observed between the NS and TTA samples indicates differences in the microbial compositions of these
sampling sites
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are needed to confirm this difference, it is reasonable to
assume that environmental factors can influence, at least
partially, nasal microbiota composition.
In fact, a variation in microbiota composition of the
upper respiratory tract of calves when they are moved in a
new environment has already been documented [26, 28].
Nevertheless, several factors have been observed to influ-
ence the development and composition of nasopharyngeal
microbiota in humans (e.g., mode of birth delivery or
breastfeeding) and possibly predispose to the development
of respiratory disease [39, 40]. Moreover, differences in
microbiota composition in relation to geographical pro-
venience have also been found in humans [41].
A limitation to our study may be the absence of a
blank control and a mock community, to calculate the
PCR error rate and to evaluate the possible presence of
contaminants in the process of DNA treatment. At the
time of this study, the inclusion of sequencing controls
was not a widespread practice and was not a part of
similar studies [25, 26, 28].
Forty-five out of the 305 genera identified were possible
contaminants, according to Salter et al. [42], but their rela-
tive abundance was low (Additional file 2: Table S1). Four
of these genera were found with a relative abundance
higher than 1% only in the NS samples: Sphingomonas,
Delftia, Psychrobacter, and Corynebacterium. The relative
abundance of contaminant genera was 0.6% in the TTA
and 11.35% in the NS samples. As suggested by Salter et
al. [42], since contaminant issues are more relevant in low
biomass samples, it could be hypothesized that the bacter-
ial load in the NS samples was lower, which would be odd,
given that the upper airways are probably far more ex-
posed to a higher environmental bacterial load [43]. A
more probable explanation is that these genera were more
abundant in the NS samples because of environmental
contamination of the upper respiratory tract, rather than
contamination occurring during the samples’ analysis due
to low biomass.
Overall, the most abundant genus identified was Myco-
plasma, which was abundantly found in all NS and TTA
samples. This genus was previously identified with high
abundance in the upper respiratory airways of both
healthy and BRD-affected calves [26, 31]. Mycoplasma is
spread worldwide, and it has frequently been isolated
also with the use of bacterial culture and PCR detection
from lower respiratory tract samples from calves, regard-
less of their clinical status [23, 24]. Unfortunately, in this
study, the lack of information about Mycoplasma species
present in the TTA samples precludes formulating a
hypothesis about their pathogenetic role. Although M.
bovis is recognized as a major etiologic agent in BRD
and otitis media, less is known about other Mycoplasma
spp., e.g., M. dispar and M. bovirhinis, which have been
detected less frequently in the bovine respiratory tract
[23, 24, 44–47]. It has been suggested that the lack of
isolation of these two species could be correlated with
an inhibitory effect of other mycoplasmas [24, 48]. Fur-
thermore, discriminatory analyses within this genus
could provide clues to determining the relationship be-
tween these species and their role in BRD.
Our observation of Moraxella, the second most abun-
dant genus identified in the NS samples, is shared by Tim-
sit et al. [26] and Lima et al. [31]. Lima et al. [31] also
found a correlation between the presence of Moraxella
and the development of BRD. In cattle, Moraxella bovis is
the etiological agent of infectious bovine keratoconjuncti-
vitis (IBK), and Moraxella genus has rarely been isolated
in the course of BRD [49, 50]. In children, the role of this
genus in the development of respiratory disease is contro-
versial and is probably correlated with the species identi-
fied. In fact, it has been associated not only with the
development of asthma and respiratory disease but also with
a more stable microbiota, which is linked to a lower risk of
developing respiratory disease [51–53]. Corynebacterium
was identified in all NS samples, and previous studies have
reported its relatively high abundance in the bovine upper
respiratory tract [25, 26, 31]. In children, it has been corre-
lated with a reduced risk of developing otitis media and re-
spiratory disease [39, 54].
Four of the five most abundant phyla identified in the
lower respiratory tract were the same as those found in
the upper respiratory tract (Proteobacteria, Tenericutes,
Actinobacteria, and Bacteroidetes), albeit with different
abundance, though Fusobacteria seemed to be character-
istic of this ecosystem. Identification of this phylum in
the bovine upper respiratory tract has rarely been re-
ported and each time with low abundance [25, 30, 31].
In other species, such as the dog and humans, Fusobac-
teria is one of the most abundant phyla found in the oral
cavity but it is less abundant in the nasopharynx [43, 55,
56]. Furthermore, in the human lung, the abundance of
Fusobacteria varies in relation to its presence in the oral
cavity, leading to the hypothesis that the oral microbial
community could be a bacterial source for lung micro-
biota composition [56–60].
The second most abundant genus identified in the TTA
samples, and the main component of the phylum Proteo-
bacteria, was Pasteurella. It was comprised mostly of P.
multocida, and it was also identified with a lower abun-
dance in the NS samples. In contrast, Pasteurellaceae
were more abundant in oral than in lung and nasal sam-
ples from dog, and a higher abundance of Pasteurellales
were found in the throat of sheep [43, 61]. P. multocida is
considered a commensal of the upper respiratory airways,
but its identification in samples from the lower respiratory
tract has usually been correlated with BRD [22, 24].
Nevertheless, Angen et al. [23] isolated P. multocida from
TTA samples obtained from clinically healthy animals.
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The absence of a significant difference in lower microbiota
composition between healthy and BRD-affected calves
suggests that P. multocida could be part of the microbial
flora of the lower respiratory tract of healthy animals.
Our results showed significant differences in alpha
diversity and beta diversity between the upper and
the lower respiratory tract microbiota: the number of
species composing the lower respiratory tract micro-
biota was lower, and these species differed by abun-
dance and type from the upper respiratory tract
microbiota. The same outcomes were obtained from
studies in humans and dogs [3, 5, 60, 62]. In humans,
the lung microbiota was found to differ significantly
from the oral and the nasal microbiota [5, 62]. In
healthy individuals, the lung microbiota partly over-
laps with the oral microbiota [5, 62], which is the main
source of the composition of the lung microbiota owing
to the constant flow of saliva from the mouth, while much
less liquid flows from the nose [60]. In upper respiratory
tract disease, there is an increased liquid flow from the
nose, with a higher potential to affect the lung microbiota
as a consequence [60].
Analysis of respiratory tract samples obtained from the
dog led to the hypothesis for a self-sustaining lung
microbiota also in this species, which proved to be much
more homogeneous than the composition of the oral or
nasal microbiota [43]. In the present study, the trans-
tracheal approach was used for the collection of samples
from the lower respiratory tract in order to minimize
the contamination from the upper respiratory ways.
Moreover, this method has been recommended as opti-
mal for evaluation of the microbiological status of the
lower respiratory tract of calves [23]. The finding of 16
genera identified only in the lower respiratory tract, al-
beit few and with low abundance, suggests that the lung
could be colonized by characteristic bacterial species
also in cattle. Unfortunately, because of the paucity of
information about the oral cavity microbiota of cattle,
no conclusions can be drawn.
Comparison by farm of origin showed a statistical dif-
ference in microbiota composition only for the NS sam-
ples. This suggests that the lower respiratory tract
microbiota may be more homogeneous and resilient
than the upper respiratory tract, in agreement with the
results found in the dog [43]. Moreover, these findings
strengthen the hypothesis for a self-sustaining lower re-
spiratory tract microbiota also in cattle.
The absence of significant differences in the bacterial
species recovered from the NS and TTA samples from
the healthy and the BRD-affected calves contrasts with
previous results obtained in humans and cattle [7, 31].
Since BRD is a syndrome and not a single disease with a
linear etiology, it may manifest clinically and microbio-
logically in several different forms [20]. Various other
factors could have influenced our results and precluded
differentiation between the microbiota of a diseased lung
and that of a healthy one. Nevertheless, the primary aim
of the present study was to characterize the microbiota
of the respiratory airways of calves examined and sam-
pled in field conditions.
Conclusions
Our findings demonstrate the presence of bacterial com-
munities in the lower respiratory tract in both healthy
calves and those presenting clinical signs of BRD. The
results obtained from the NS samples suggest that envir-
onmental factors (farm, management) may influence the
microbial composition of the bovine upper respiratory
tract. The finding of bacterial communities in the lower
respiratory tract, which differed from the ones found in
the upper respiratory tract, suggests the presence of a
self-sustaining microbiota at this level. Further studies
including characterization of the oral cavity microbiota
are needed to confirm this hypothesis.
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